tiprankstipranks
Regen Biopharma (RGBP)
OTHER OTC:RGBP
US Market

Regen Biopharma (RGBP) Technical Analysis

64 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Regen Biopharma’s (RGBP) Moving Averages Convergence Divergence (MACD) indicator is -0.08, suggesting Regen Biopharma is a Buy.
Regen Biopharma’s (RGBP) 20-Day exponential moving average is 0.52, while Regen Biopharma’s (RGBP) share price is $0.31, making it a Sell.
Regen Biopharma’s (RGBP) 50-Day exponential moving average is 0.60, while Regen Biopharma’s (RGBP) share price is $0.31, making it a Sell.

Regen Biopharma (RGBP) Pivot Points

Jul 22, 2024, 09:29 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.40
0.40
0.40
0.40
0.40
0.40
0.40
Fibonacci
0.40
0.40
0.40
0.40
0.40
0.40
0.40
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Regen Biopharma (RGBP) Moving Averages

Jul 22, 2024, 09:29 AM
Period
Simple
Exponential
MA5
0.42Sell
0.40Sell
MA10
0.44Sell
0.45Sell
MA20
0.52Sell
0.52Sell
MA50
0.64Sell
0.60Sell
MA100
0.62Sell
0.66Sell
MA200
0.81Sell
0.86Sell
Regen Biopharma’s (RGBP) 10-Day exponential moving average is 0.45, while Regen Biopharma’s (RGBP) share price is $0.31, making it a Sell.
Regen Biopharma’s (RGBP) 100-Day exponential moving average is 0.66, while Regen Biopharma’s (RGBP) share price is $0.31, making it a Sell.
Regen Biopharma’s (RGBP) stock price is $0.31 and Regen Biopharma’s (RGBP) 50-day simple moving average is 0.64, creating a Sell signal.
Regen Biopharma’s (RGBP) stock price is $0.31 and Regen Biopharma’s (RGBP) 100-day simple moving average is 0.62, creating a Sell signal.
Regen Biopharma’s (RGBP) stock price is $0.31 and Regen Biopharma’s (RGBP) 200-day simple moving average is 0.81, creating a Sell signal.

Regen Biopharma (RGBP) Technical Indicators

Jul 22, 2024, 09:29 AM
Name
Value
Implied Action
RSI (14)
36.41
Neutral
STOCH (9,6)
29.38
Neutral
STOCHRSI (14)
22.61
Neutral
MACD (12,26)
-0.08
Buy
ADX (14)
43.33
Neutral
Williams %R
-89.61
Buy
CCI (14)
-126.66
Buy
ATR (14)
0.17
-
Ultimate Oscillator
45.28
Neutral
ROC
-42.59
Sell
Regen Biopharma’s (RGBP) Relative Strength Index (RSI) is 36.41, creating a Neutral signal.
Regen Biopharma’s (RGBP) Trend Strength Indicator (ADX) is 43.33, creating a Neutral signal.
Regen Biopharma’s (RGBP) Commodity Channel Index (CCI) is -126.66, creating a Buy signal.
Regen Biopharma’s (RGBP) Price Rate of Change (ROC) is -42.59, creating a Sell signal.

FAQ

Is RGBP a Buy, Hold, or Sell?
Based on RGBP’s technical indicators, RGBP is a Strong Sell.
    What is RGBP’s RSI (14)?
    RGBP’s RSI (14) is 36.41, which suggests RGBP is a Neutral.
      What is RGBP’s MACD?
      RGBP’s MACD is -0.08, which suggests RGBP is a Buy.
        What is RGBP’s 5-day moving average?
        RGBP’s 5-day moving average is 0.42, which suggests RGBP is a Sell.
          What is RGBP’s 20-day moving average?
          RGBP 20-day moving average is 0.52, which suggests RGBP is a Sell.
            What is RGBP’s 50-day moving average?
            RGBP’s 50-day moving average is 0.64, which suggests RGBP is a Sell.
              What is RGBP’s 200-day moving average?
              RGBP’s 200-day moving average is 0.81, which suggests RGBP is a Sell.
                What is RGBP’s Williams % R (14)?
                RGBP’s Williams % R (14) is -89.61, which suggests RGBP is a Buy.
                  What is RGBP’s CCI (14)?
                  RGBP’s CCI (14) is -126.66, which suggests RGBP is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis